Filed: 2/14/2024ACC: 0000950123-24-002337
📋 What this filing means
BELLEVUE GROUP AG filed this quarterly 13F‑HR report disclosing 161 equity positions with a total reported market value of $6.54B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
161
Positions
$6.54B
Total AUM (reported)
154.30M
Total Shares
Allocation by class
COM$4.98B76.2%
COM NEW$593.21M9.1%
SPONSORED ADR$339.36M5.2%
CL A$166.74M2.6%
SHS$104.11M1.6%
COM PAR $.01$71.00M1.1%
ADS$66.68M1.0%
Portfolio Concentration
Top 3$1.09B16.7%
4–10$1.51B23.1%
11–25$1.52B23.2%
Rest$2.42B37.0%
Top 3 weight
16.7%
Top 10 weight
39.8%
Voting Authority Distribution
Total shares with voting rights: 154.30M
Sole
Full voting authority
154.30M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other161
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings161
Rows:
IONIS PHARMACEUTICALS INC
DFNDShares8.71M
TypeSH
Market value$440.84M
6.74%
Sole
8.71M
Shared
0.00
None
0.00
ARGENX SE
DFNDShares869.21K
TypeSH
Market value$330.68M
5.06%
Sole
869.21K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
DFNDShares2.43M
TypeSH
Market value$320.24M
4.90%
Sole
2.43M
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
DFNDShares736.39K
TypeSH
Market value$299.63M
4.58%
Sole
736.39K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
DFNDShares832.04K
TypeSH
Market value$280.70M
4.29%
Sole
832.04K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
DFNDShares3.07M
TypeSH
Market value$219.62M
3.36%
Sole
3.07M
Shared
0.00
None
0.00
MODERNA INC
DFNDShares1.91M
TypeSH
Market value$189.79M
2.90%
Sole
1.91M
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
DFNDShares3.17M
TypeSH
Market value$183.29M
2.80%
Sole
3.17M
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
DFNDShares885.32K
TypeSH
Market value$169.46M
2.59%
Sole
885.32K
Shared
0.00
None
0.00
ABBOTT LABS
DFNDShares1.54M
TypeSH
Market value$169.03M
2.59%
Sole
1.54M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
DFNDShares5.09M
TypeSH
Market value$146.01M
2.23%
Sole
5.09M
Shared
0.00
None
0.00
STRYKER CORPORATION
DFNDShares465.72K
TypeSH
Market value$139.47M
2.13%
Sole
465.72K
Shared
0.00
None
0.00
INCYTE CORP
DFNDShares2.16M
TypeSH
Market value$135.42M
2.07%
Sole
2.16M
Shared
0.00
None
0.00
AXONICS INC
DFNDShares1.83M
TypeSH
Market value$114.08M
1.74%
Sole
1.83M
Shared
0.00
None
0.00
DEXCOM INC
DFNDShares914.59K
TypeSH
Market value$113.49M
1.74%
Sole
914.59K
Shared
0.00
None
0.00
ARVINAS INC
DFNDShares2.51M
TypeSH
Market value$103.22M
1.58%
Sole
2.51M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
DFNDShares2.42M
TypeSH
Market value$95.83M
1.47%
Sole
2.42M
Shared
0.00
None
0.00
MACROGENICS INC
DFNDShares9.95M
TypeSH
Market value$95.75M
1.46%
Sole
9.95M
Shared
0.00
None
0.00
BECTON DICKINSON & CO
DFNDShares388.07K
TypeSH
Market value$94.62M
1.45%
Sole
388.07K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
DFNDShares4.01M
TypeSH
Market value$89.32M
1.37%
Sole
4.01M
Shared
0.00
None
0.00
MEDTRONIC PLC
DFNDShares970.77K
TypeSH
Market value$79.97M
1.22%
Sole
970.77K
Shared
0.00
None
0.00
EVOLENT HEALTH INC
DFNDShares2.38M
TypeSH
Market value$78.51M
1.20%
Sole
2.38M
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
DFNDShares1.02M
TypeSH
Market value$77.70M
1.19%
Sole
1.02M
Shared
0.00
None
0.00
EXACT SCIENCES CORP
DFNDShares1.05M
TypeSH
Market value$77.52M
1.19%
Sole
1.05M
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
DFNDShares3.51M
TypeSH
Market value$76.13M
1.16%
Sole
3.51M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IONIS PHARMACEUTICALS INCDFND | COM | 8.71M | SH | $440.84M 6.74% | 8.71M | 0.00 | 0.00 |
ARGENX SEDFND | SPONSORED ADR | 869.21K | SH | $330.68M 5.06% | 869.21K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCDFND | COM | 2.43M | SH | $320.24M 4.90% | 2.43M | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCDFND | COM | 736.39K | SH | $299.63M 4.58% | 736.39K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCDFND | COM NEW | 832.04K | SH | $280.70M 4.29% | 832.04K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCDFND | COM | 3.07M | SH | $219.62M 3.36% | 3.07M | 0.00 | 0.00 |
MODERNA INCDFND | COM | 1.91M | SH | $189.79M 2.90% | 1.91M | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPDFND | COM | 3.17M | SH | $183.29M 2.80% | 3.17M | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCDFND | COM | 885.32K | SH | $169.46M 2.59% | 885.32K | 0.00 | 0.00 |
ABBOTT LABSDFND | COM | 1.54M | SH | $169.03M 2.59% | 1.54M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCDFND | COM | 5.09M | SH | $146.01M 2.23% | 5.09M | 0.00 | 0.00 |
STRYKER CORPORATIONDFND | COM | 465.72K | SH | $139.47M 2.13% | 465.72K | 0.00 | 0.00 |
INCYTE CORPDFND | COM | 2.16M | SH | $135.42M 2.07% | 2.16M | 0.00 | 0.00 |
AXONICS INCDFND | COM | 1.83M | SH | $114.08M 1.74% | 1.83M | 0.00 | 0.00 |
DEXCOM INCDFND | COM | 914.59K | SH | $113.49M 1.74% | 914.59K | 0.00 | 0.00 |
ARVINAS INCDFND | COM | 2.51M | SH | $103.22M 1.58% | 2.51M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWDFND | COM NEW | 2.42M | SH | $95.83M 1.47% | 2.42M | 0.00 | 0.00 |
MACROGENICS INCDFND | COM | 9.95M | SH | $95.75M 1.46% | 9.95M | 0.00 | 0.00 |
BECTON DICKINSON & CODFND | COM | 388.07K | SH | $94.62M 1.45% | 388.07K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCDFND | COM | 4.01M | SH | $89.32M 1.37% | 4.01M | 0.00 | 0.00 |
MEDTRONIC PLCDFND | SHS | 970.77K | SH | $79.97M 1.22% | 970.77K | 0.00 | 0.00 |
EVOLENT HEALTH INCDFND | CL A | 2.38M | SH | $78.51M 1.20% | 2.38M | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPDFND | COM | 1.02M | SH | $77.70M 1.19% | 1.02M | 0.00 | 0.00 |
EXACT SCIENCES CORPDFND | COM | 1.05M | SH | $77.52M 1.19% | 1.05M | 0.00 | 0.00 |
SAGE THERAPEUTICS INCDFND | COM | 3.51M | SH | $76.13M 1.16% | 3.51M | 0.00 | 0.00 |
Page 1 of 7
…